Selexipag


( Last Updated : February 16, 2016)
Generic Name:
Selexipag
Project Status:
Complete
Therapeutic Area:
Pulmonary arterial hypertension (WHO class II and III)
Manufacturer:
Actelion Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Uptravi
Project Line:
Reimbursement Review
Project Number:
SR0482-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Pulmonary arterial hypertension (WHO class II and III)
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation: